2022-2027 Middle East Automated Microbiology Market in 11 Countries--Growth Opportunities, 2022 Supplier Shares by Assay, 5-Year Segmentation Forecasts for over 100 Molecular, Identification, Susceptibility, Culture, Urine Screening and Immunodiagnostic Tests--Competitive Strategies and SWOT Analysis, Instrumentation Pipeline, Emerging Technologies, Market Barriers and Risks

Abstract

This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years.

The report is available by section, and can be customized to specific information needs and budget. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratories still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 11-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Specimen Types

- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva

Applications

-Microbial Identification
-Antibiotic Susceptibility
-Urine Screening
-Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Halifax, BD, Beckman Coulter/Danaher, Biolog, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG, Labsystems, Qiagen, Roche, Siemens Healthineers, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Companies developing or marketing microbiology products, by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Content
Table of Contents and List of Tables

I. Introduction
II. Automated Microbiology Market Business Environment
III. New Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Market and Technology Overview
A. Introduction
1. Major Factors Affecting Market Penetration for Microbiology Instrumentation
2. Traditional Practices
3. Technological Challenges
4. Automation: Impact on the Microbiology Laboratory and the Patient
B. Major Specimen Types
1. Urine
2. Sterile Fluids: Blood, Serum, and CSF
3. Throat Swabs and Respiratory Secretions
4. Genital Secretions
5. Stool
6. Abscess/Wound
7. Sputum
8. Saliva
C. Test Applications
1. Microbial Identification
2. Antibiotic Susceptibility
3. Urine Screening
a. Photometry
b. Bioluminescence
c. Colorimetric Filtration
d. Enzymatic Detection
e. Optical Detection
4. Blood Cultures
D. Major Automated and Semi-automated Microbiology Systems
1. Multiple Purpose Microbiology Systems
2. Specialized Microbiology Systems
3. Molecular Diagnostic Systems
4. Immunodiagnostic Systems
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
a. DNA Sequencing
b. DNA and RNA Probe Technologies
c. Detection Technologies
d. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VIII. Country Analyses: Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial
Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests,
Supplier Shares
- Bahrain
- Iran
- Iraq
- Israel
- Jordan
- Kuwait
- Lebanon
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
IX. Competitive
Assessments
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujifilm Wako
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- OrthoQuidel
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh

List of Tables
Bahrain
Microbiology Specimen Volume Forecast by Type
Bahrain
Microbiology Test Volume Forecasts by Application
Bahrain
Microbiology Consumables Market Forecast by Application
Bahrain
Infectious Disease Test Volume Forecast by Assay
Bahrain
Infectious Disease Diagnostics Market Forecast by Test
Bahrain
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Bahrain
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Iran
Microbiology Specimen Volume Forecast by Type
Iran
Microbiology Test Volume Forecasts by Application
Iran
Microbiology Consumables Market Forecast by Application
Iran
Infectious Disease Test Volume Forecast by Assay
Iran
Infectious Disease Diagnostics Market Forecast by Test
Iran
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Iran
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Iraq
Microbiology Specimen Volume Forecast by Type
Iraq
Microbiology Test Volume Forecasts by Application
Iraq
Microbiology Consumables Market Forecast by Application
Iraq
Infectious Disease Test Volume Forecast by Assay
Iraq
Infectious Disease Diagnostics Market Forecast by Test
Iraq
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Iraq
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Israel
Microbiology Specimen Volume Forecast by Type
Israel
Microbiology Test Volume Forecasts by Application
Israel
Microbiology Consumables Market Forecast by Application
Israel
Infectious Disease Test Volume Forecast by Assay
Israel
Infectious Disease Diagnostics Market Forecast by Test
Israel
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Israel
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Jordan
Microbiology Specimen Volume Forecast by Type
Jordan
Microbiology Test Volume Forecasts by Application
Jordan
Microbiology Consumables Market Forecast by Application
Jordan
Infectious Disease Test Volume Forecast by Assay
Jordan
Infectious Disease Diagnostics Market Forecast by Test
Jordan
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Jordan
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Kuwait
Microbiology Specimen Volume Forecast by Type
Kuwait
Microbiology Test Volume Forecasts by Application
Kuwait
Microbiology Consumables Market Forecast by Application
Kuwait
Infectious Disease Test Volume Forecast by Assay
Kuwait
Infectious Disease Diagnostics Market Forecast by Test
Kuwait
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Kuwait
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Lebanon
Microbiology Specimen Volume Forecast by Type
Lebanon
Microbiology Test Volume Forecasts by Application
Lebanon
Microbiology Consumables Market Forecast by Application
Lebanon
Infectious Disease Test Volume Forecast by Assay
Lebanon
Infectious Disease Diagnostics Market Forecast by Test
Lebanon
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Lebanon
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Oman
Microbiology Specimen Volume Forecast by Type
Oman
Microbiology Test Volume Forecasts by Application
Oman
Microbiology Consumables Market Forecast by Application
Oman
Infectious Disease Test Volume Forecast by Assay
Oman
Infectious Disease Diagnostics Market Forecast by Test
Oman
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Oman
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Qatar
Microbiology Specimen Volume Forecast by Type
Qatar
Microbiology Test Volume Forecasts by Application
Qatar
Microbiology Consumables Market Forecast by Application
Qatar
Infectious Disease Test Volume Forecast by Assay
Qatar
Infectious Disease Diagnostics Market Forecast by Test
Qatar
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Qatar
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Saudi Arabia
Microbiology Specimen Volume Forecast by Type
Saudi Arabia
Microbiology Test Volume Forecasts by Application
Saudi Arabia
Microbiology Consumables Market Forecast by Application
Saudi Arabia
Infectious Disease Test Volume Forecast by Assay
Saudi Arabia
Infectious Disease Diagnostics Market Forecast by Test
Saudi Arabia
Infectious Disease Blood Screening NAT Volume Forecast by Assay
Saudi Arabia
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
United Arab Emirates
Microbiology Specimen Volume Forecast by Type
United Arab Emirates
Microbiology Test Volume Forecasts by Application
United Arab Emirates
Microbiology Consumables Market Forecast by Application
United Arab Emirates
Infectious Disease Test Volume Forecast by Assay
United Arab Emirates
Infectious Disease Diagnostics Market Forecast by Test
United Arab Emirates
Infectious Disease Blood Screening NAT Volume Forecast by Assay
United Arab Emirates
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests Major
Companies Developing or Marketing Clostridium Tests Major
Companies Developing or Marketing Coronavirus Tests Major
Companies Developing or Marketing Cryptosporidium Tests Major
Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests Major
Companies Developing or Marketing Lyme Disease Tests Major
Companies Developing or Marketing Lymphogranuloma Tests Major
Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests Major
Companies Developing or Marketing Meningitis Tests Major
Companies Developing or Marketing Microsporidium Tests Major
Companies Developing or Marketing Mononucleosis Tests Major
Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests